A neuroscientist combining academic and pharmaceutical business, research and development (R&D) experience who previously led strategic, scientific and operational multi-national, cross-functional teams in R&D and external innovation with academic, pharma, and National Institutes of Health connections. Previously led a laboratory of medical students and neurosurgeons in research centered on cerebral ischemia and stroke as an Assistant Professor in Surgery (Neurosurgery) at Harvard Medical School and Assistant Neuroscientist in the Neurosurgical Service, at Massachusetts General Hospital. Published 50+ primarily original publications in international, peer-reviewed journals, excluding abstracts. Formerly served on the editorial committees of the American Journal of Pharmacology and Toxicology, Current Neurobiological Research, Current Neurovascular Research and Recent Patent Reviews on CNS Drug Discovery. Past leadership roles include serving on the Executive Committee of the International Dose-Response Society; Chair, Membership and Communications Committee and held advocacy discussions with 2 members of the US Congress and was a participant in the White House Community Leaders Briefing on Cardiovascular Health for the American Heart Association/American Stroke Association’s Stroke Council. Currently serving as a member of the Society for Neuroscience’s Finance Committee as Treasurer. Invited speaker and panelist covering various topics including, New Models of Innovation, Hormesis and the Pharmaceutical Industry, Winning in the CNS R&D Space and Research Careers in the Private Sector. Specialties: Subject matter expertise in neuroscience, especially cerebrovascular pathophysiology, specifically stroke.